Duke   

Questions discussed in this category



Do you observe, offer adjuvant pembrolizumab, or give a first-line metastatic regimen (IO/IO or IO/TKI)? Does your recommendation vary based on risk c...

Would you use it for initial staging or at time of biochemical recurrence?

GS 4+4. PSA low (1-2). CT and bone scan negative for lymphadenopathy or metastatic disease.  Prostate MRI pending. 

Does patient age effect your approach? Would you consider RPLND for any patients in light of the phase II SEMS trial presented at the 2021 ASCO GU Ca...


Papers discussed in this category


Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001-03-15

Clin Nutr, 2015 Aug 28

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-03-10

Clinical genitourinary cancer, 2018-12

J Urol, 2020 Apr

Lancet, 2020 Mar 05

Oncologist, 2020 Dec 03

Urology, 2000-11-01

Abdom Radiol (NY), 2019 Aug 29

J Urol, 2021 Feb 26

Eur Urol Oncol, 2019 Sep 19

N Engl J Med,